Eagle Announces Acquisition of Acacia in Strategic Good Fit

Eagle Announces Acquisition of Acacia in Strategic Good Fit

Source: 
BioSpace
snippet: 

New Jersey-based Eagle Pharmaceuticals, a company geared towards pharmaceutical hospital sales, has finalized terms to acquire Acacia Pharma. Closure of the acquisition is expected in the late second quarter of 2022. In order to meet this timeframe, shareholders of both companies will have to approve the transaction.